Injection Site Haemorrhage
also: Injection Site Hemorrhage
12 drugs21,396 FAERS reportsMedDRA PT
GET
/api/v1/reaction/injection-site-haemorrhageReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
Drugs reporting Injection Site Haemorrhage (12)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Galcanezumab1,5475.1%
- 2Teriparatide4,4984.0%
- 3Dulaglutide3,1453.6%
- 4Tirzepatide5,0353.6%
- 5Exenatide1,8093.5%
- 6Alirocumab6852.8%
- 7Evolocumab3,8932.5%
- 8Lenacapavir81.9%
- 9Somatrogon201.7%
- 10Ixekizumab6001.7%
- 11Nemolizumab1471.5%
- 12Mirikizumab91.2%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Injection Site Bruising10 shared · 0.33
- Accidental Underdose3 shared · 0.20
- Injection Site Erythema8 shared · 0.18
- Injection Site Pruritus5 shared · 0.16
- Injection Site Discomfort2 shared · 0.13
- Injection Site Swelling4 shared · 0.13
- Device Difficult To Use2 shared · 0.13
- Incorrect Dose Administered By Device2 shared · 0.13
- Device Use Error2 shared · 0.12
- Injection Site Mass3 shared · 0.11
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.